The Recall Desk
HighFDA (Devices)·Z-1479-2022·Announced 2022-08-03

Revogene diagnostic test instrument recalled for burn risk from cooling failure

Meridian Bioscience recalled 459 Revogene diagnostic instruments due to a cooling protection failure that may expose users to heated components, risking minor burn injuries.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This defect is classified as High because it presents a risk-of-harm scenario where injury has not yet been reported. Although the cooling system malfunction could cause minor burns, the source explicitly states no hospitalizations or actual injuries have occurred, meeting the rubric criterion for Score 3.

Plain-English summary

Meridian Bioscience Inc is recalling the Revogene diagnostic test instrument (catalog no. 610210), an in vitro diagnostic device. A total of 459 units have been recalled, distributed in the US and to Australia, Chile, Italy, Qatar, and Switzerland.

The recall stems from a safety defect: when a test run is aborted, the device's cooling period protection does not activate. This allows operators to open the instrument lid before the cooling cycle is complete, exposing them to heated instrument components.

Incidental contact with the heated components may cause minor burn injuries. The affected devices have firmware version V2.1.0 and are identified by specific serial numbers listed in the recall notice. Affected facilities should verify their device's firmware version and serial number against the recall documentation.

The recalled product

Product
Revogene, Catalog no. 610210. IVD test instrument
Manufacturer
Meridian Bioscience Inc
Hazard
  • burn-injury

Distribution

Distributed nationwide across the United States.